InsidersTradesSigma
Track the Prostatype Genomics BTU stock price and the full directors' dealings record of the company, a publicly traded company based in Finland. Shares trade on the FI market, under the oversight of FIN-FSA. Market capitalisation: €23.3m. The latest transaction was filed on 5 August 2026 (Purchase). Among the most active insiders: Jörgen Dahlström. The full history is openly available.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Prostatype Genomics BTU is a company focused on developing genomic tests for prostate cancer. It is listed on the XSTO market.